Related Experiment Videos
[Malignant lymphoma of the thyroid gland]
N Maniwa1, N Takeichi, M Matsuyama
12nd Dept. of Surgery, School of Med., Hiroshima Univ.
Gan No Rinsho. Japan Journal of Cancer Clinics
|October 1, 1988
Summary
Malignant thyroid lymphoma survival rates vary by grade, with low and intermediate grades showing better outcomes. Treatment should align with the Working Formulation subtype for optimal results in thyroid lymphoma cases.
Area of Science:
- Oncology
- Pathology
- Endocrinology
Context:
- Thyroid malignant lymphoma is a rare condition.
- Review of 14 cases over 14 years.
- Histological reclassification using the Working Formulation.
Purpose:
- To reclassify thyroid malignant lymphoma cases.
- To analyze survival rates based on malignancy grade and cell type.
- To establish treatment guidelines based on histological subtypes.
Summary:
- 14 thyroid malignant lymphoma cases were reviewed and classified.
- Low grade malignancy (LGM) and intermediate malignancy (IGM) groups had survivors, unlike high grade malignancy (HGM).
- Most lymphomas were B-cell type (13/14), with 9 cases coexisting with chronic thyroiditis.
Impact:
- Highlights the prognostic significance of malignancy grade in thyroid lymphoma.
- Suggests tailored treatment strategies based on Working Formulation subtypes.
- Informs clinical decision-making for rare thyroid malignancies.